Letter to the editor submitted in response to "Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial."

Letter to the editor submitted in response to "Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial." J Dermatolog Treat. 2019 Aug 22;:1-4 Authors: Axon E, Grindlay DJ PMID: 31437067 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31437067?dopt=Abstract

Source: Journal of Dermatological Treatment - August 24, 2019 Category: Dermatology Tags: J Dermatolog Treat Source Type: research